Predisposing Factors of Atrial High-rate Episodes in Patients with Permanent Pacemaker Implantation in Central Chest Institute of Thailand
Keywords:
AHREs, Atrial fibrillation, Pacemaker, Stroke, Predisposing factorsAbstract
Background: The atrial high-rate episodes (AHREs) are considered clinically correlated with atrial fibrillation (AF). Moreover, the stroke risk is increasing following the AHREs burden and/or CHA2 DS2 -VASc score. However, the predisposing factors of the AHREs were not clearly known. Objective: To investigate the predisposing factors of AHREs in patients with dual-chamber pacemakers. Method: This study was a retrospective observational study recruiting patients without history of AF prior to the dual-chamber pacemaker implantation. Patients with evidences of other atrial tachyarrhythmias prior to the dual-chamber pacemaker implantation were excluded. The baseline demographic data, past medical history, medications, echocardiographic parameters, electrocardiographic findings and pacemaker interrogation data were analyzed and compared between patients with and without AHREs. Predisposing factors predicting AHREs was analyzed by using univariate and multivariate logistic regression analysis. Result: A total of 239 patients undergoing dual-chamber pacemaker implantation in Central Chest Institute of Thailand among January 2017 to December 2021 were recruited. The data of 117 patients from 239 patients were analyzed. There were 89 patients had no AHREs and 28 patients had AHREs. Multivariate logistic regression analysis showed that the percentage of atrial pacing was significantly greater in patients with AHREs (odds ratio 1.02; 95% CI 1.003 to 1.041; p-value = .021). Conclusion: Increased atrial pacing was the only predisposing factor of AHREs in Thai patients with permanent pacemaker. However, larger prospective study should be studied in the future.
References
Rapsang AG, Bhattacharyya P. Pacemakers and implantable cardioverter defibrillators--general and anesthetic considerations. Braz J Anesthesiol 2014;64 (3):205-14.
Greenspan AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol 2012;60(16):1540-5.
Bernsein AD, Daubert JC, Fletcher RD, Hayes DL, Lüderitz B, Reynold DW, et al. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of pacing and electrophysiology/British pacing and electrophysiology group. Pacing Clin Electrophysiol 2002;25(2):260-4.
Epstein AE, DiMarco JP, Ellenbogen KA, Estes 3rd NAM, Freedman RA, Gettes LS, et al. 2012 ACCF/ AHA/HRS focused update incorporated into the ACCF/AHA/ HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2013;61(3):e6-75.
Stone ME, Salter B, Fischer A. Perioperative management of patients with cardiac implantable electronic devices. Br J Anaesth 2011;107(Suppl 1):i16-26.
Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 2003; 107(12):1614-9.
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 2020;42(5):373-498.
Khan AA, Boriani G, Lip GYH. Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation? Clin Res Cardiol 2020;109(4):409-16.
Bertaglia E, Blank B, Blomström-Lundqvist C, Brandes A, Cabanelas N, Dan GA, et al. Atrial highrate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence. Europace 2019;21(10):1459-67.
Boriani G, Vitolo M, Imberti JF, Potpara TS, Lip GYH. What do we do about atrial high rate episodes? Eur Heart J Suppl 2020;22(Suppl O):O42-O52.
Mahajan R, Perera T, Elliott AD, Twomey DJ, Kumar S, Munwar DA, et al. Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta- analysis. Eur Heart J 2018;39(16):1407–15.
Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366(2):120–9.
Chen JH, Chen GY, Zheng H, Chen QH, Fu FY, Zhang FL, et al. Atrial high-rate event incidence and predictors in patients with permanent pacemaker implantation. Front Cardiovasc Med 2021;8:728885.
Miyazawa K, Pastori D, Martin DT, Choucair WK, Halperin JL, Lip GYH. Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices. Europace 2022;24(3):375-83.
Healey JS, Alings M,Ha A, Leong-Sit P, Birnie DH, de Graaf JJ, et al. Subclinical atrial fibrillation in older patients. Circulation 2017;136(14):1276-83.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Department of Medical Services, Ministry of Public Health
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของกรมการแพทย์ กระทรวงสาธารณสุข
ข้อความและข้อคิดเห็นต่างๆ เป็นของผู้เขียนบทความ ไม่ใช่ความเห็นของกองบรรณาธิการหรือของวารสารกรมการแพทย์
